ATE61937T1 - Antigenische zubereitungen und isolierung von solchen zubereitungen. - Google Patents
Antigenische zubereitungen und isolierung von solchen zubereitungen.Info
- Publication number
- ATE61937T1 ATE61937T1 AT85303302T AT85303302T ATE61937T1 AT E61937 T1 ATE61937 T1 AT E61937T1 AT 85303302 T AT85303302 T AT 85303302T AT 85303302 T AT85303302 T AT 85303302T AT E61937 T1 ATE61937 T1 AT E61937T1
- Authority
- AT
- Austria
- Prior art keywords
- preparations
- isolation
- antigenic
- antigenic preparations
- pertussis
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 5
- 230000000890 antigenic effect Effects 0.000 title abstract 3
- 238000002955 isolation Methods 0.000 title abstract 2
- 241000588832 Bordetella pertussis Species 0.000 abstract 1
- 201000005702 Pertussis Diseases 0.000 abstract 1
- 102000030621 adenylate cyclase Human genes 0.000 abstract 1
- 108060000200 adenylate cyclase Proteins 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB848412207A GB8412207D0 (en) | 1984-05-12 | 1984-05-12 | Antigenic preparations |
EP85303302A EP0162639B1 (de) | 1984-05-12 | 1985-05-10 | Antigenische Zubereitungen und Isolierung von solchen Zubereitungen |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE61937T1 true ATE61937T1 (de) | 1991-04-15 |
Family
ID=10560891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT85303302T ATE61937T1 (de) | 1984-05-12 | 1985-05-10 | Antigenische zubereitungen und isolierung von solchen zubereitungen. |
Country Status (13)
Country | Link |
---|---|
US (8) | US5648080A (de) |
EP (1) | EP0162639B1 (de) |
JP (3) | JPH07116053B2 (de) |
AT (1) | ATE61937T1 (de) |
CA (1) | CA1253073A (de) |
DE (1) | DE3582272D1 (de) |
DK (1) | DK165358C (de) |
ES (1) | ES8802275A1 (de) |
FI (1) | FI81262C (de) |
GB (1) | GB8412207D0 (de) |
LU (1) | LU90203I2 (de) |
NL (1) | NL980006I1 (de) |
NO (2) | NO165478C (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8412207D0 (en) * | 1984-05-12 | 1984-06-20 | Wellcome Found | Antigenic preparations |
FR2597344B1 (fr) * | 1986-04-16 | 1989-06-23 | Merieux Inst | Perfectionnement au procede de purification d'antigenes proteiques de bacteries appartenant au genre bordetella, en vue de l'obtention d'un vaccin acellulaire. |
US4762710A (en) * | 1986-06-16 | 1988-08-09 | The United States Of America As Represented By The Department Of Health And Human Services | Novel method of preparing toxoid by oxidation and metal ions |
SE455946B (sv) * | 1986-10-20 | 1988-08-22 | Trion Forskning & Utveckling | Nya pertussistoxin-polypeptider och antigener samt testsatser, vacciner och intradermala hudtestkompositioner |
EP0267998A1 (de) * | 1986-11-17 | 1988-05-25 | Institut Pasteur | Mittel zur Unterstützung gegen Infektion und Vergiftung von Bordetella |
FR2606789B1 (fr) * | 1986-11-17 | 1991-05-31 | Pasteur Institut | Preparations d'adenylate cyclase purifiees, procede d'obtention de ces preparations et leurs applications biologiques |
CA1337859C (en) * | 1987-04-24 | 1996-01-02 | Masashi Chazono | Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine |
US5139776A (en) * | 1987-04-24 | 1992-08-18 | The Research Foundation For Microbial Diseases Of Osaka University | Method for culturing Bordetella pertussis, a pertussis toxoid and a pertussis vaccine |
EP0338170A1 (de) * | 1988-04-19 | 1989-10-25 | Institut Pasteur | Immunschutz gewährendes antigenes Protein gegen pathogene Bakterien |
ES2091186T3 (es) * | 1988-04-19 | 1996-11-01 | Pasteur Institut | Procedimiento para obtener antigenos protectores contra infecciones y procesos toxicos de bordetella. |
GB8910570D0 (en) | 1989-05-08 | 1989-06-21 | Wellcome Found | Acellular vaccine |
FR2646776B1 (fr) | 1989-05-12 | 1994-06-03 | Pasteur Institut | Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella |
ATE121754T1 (de) * | 1989-09-04 | 1995-05-15 | Wellcome Found | Vakzine gegen bordetella. |
US5276142A (en) * | 1989-12-11 | 1994-01-04 | American Cyanamid Company | Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis |
US6197548B1 (en) | 1990-04-02 | 2001-03-06 | Medeva Pharma Limited | Transformed Pichia expressing the pertactin antigen |
GB9007657D0 (en) * | 1990-04-04 | 1990-05-30 | Connaught Lab | Purification of a pertussis outer membrane protein(omp69) |
EP0484621A3 (en) * | 1990-07-11 | 1992-08-26 | American Cyanamid Company | Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens |
GB9021004D0 (en) * | 1990-09-27 | 1990-11-07 | Wellcome Found | Acellular vaccines |
US6444211B2 (en) | 1991-04-03 | 2002-09-03 | Connaught Laboratories, Inc. | Purification of a pertussis outer membrane protein |
GB9304399D0 (en) * | 1993-03-04 | 1993-04-21 | Smithkline Beecham Biolog | Novel process |
FR2728170A1 (fr) * | 1994-12-15 | 1996-06-21 | Pasteur Institut | Vaccin de type acellulaire anti-bordetella |
FR2736064B1 (fr) | 1995-06-30 | 1997-09-05 | Pasteur Institut | Epitopes protecteurs de l'adenyl cyclase-hemolysine(ac-hty). leur application au traitement ou a la prevention des infections par bordetella |
ZA981370B (en) * | 1997-02-20 | 1998-09-07 | Cerberus Developments Bv | Method and apparatus for continuous flow isoelectric focusing for purifying biological substances |
GB201105981D0 (en) | 2011-04-08 | 2011-05-18 | Glaxosmithkline Biolog Sa | Novel process |
ES2597832T3 (es) | 2013-03-08 | 2017-01-23 | Janssen Vaccines & Prevention B.V. | Vacuna acelular contra la tosferina |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3141824A (en) * | 1961-05-19 | 1964-07-21 | Lilly Co Eli | Pertussis antigen |
US3395219A (en) * | 1964-12-11 | 1968-07-30 | Merck & Co Inc | Process for production of pertussis antigen |
US3465078A (en) * | 1965-10-21 | 1969-09-02 | Sydney Z Spiesel | Method of recovering antigens from bordetella pertussis cells |
FR2047886A1 (en) * | 1969-06-30 | 1971-03-19 | Merieux Inst | Non-toxic anti-whooping cough vaccine |
FR2393065A1 (fr) * | 1977-05-31 | 1978-12-29 | Merieux Inst | Procede de separation de lipides d'endotoxines bacteriennes et notamment d'endotoxine de bordetella pertussis |
EP0004137B1 (de) * | 1978-02-17 | 1981-11-11 | National Research Development Corporation | Immunologische Zellhüllepräparate |
GB2014452B (en) * | 1978-02-17 | 1982-07-21 | Secr Social Service Brit | Producing cell envelope preparations |
JPS5750925A (en) * | 1980-09-12 | 1982-03-25 | Takeda Chem Ind Ltd | Preparation of pertussis toxoid |
US4551429A (en) * | 1983-09-15 | 1985-11-05 | American Home Products Corporation | Stimulation of antigen production by Bordetella pertussis |
US5237052A (en) * | 1984-05-12 | 1993-08-17 | Burroughs Wellcome Company | Antigenic preparations and isolation of such preparations |
GB8412207D0 (en) * | 1984-05-12 | 1984-06-20 | Wellcome Found | Antigenic preparations |
US4705686A (en) * | 1986-05-09 | 1987-11-10 | American Cyanamid | Process for the preparation of acellular Bordetalla pertussis vaccine |
FR2606789B1 (fr) * | 1986-11-17 | 1991-05-31 | Pasteur Institut | Preparations d'adenylate cyclase purifiees, procede d'obtention de ces preparations et leurs applications biologiques |
EP0267998A1 (de) * | 1986-11-17 | 1988-05-25 | Institut Pasteur | Mittel zur Unterstützung gegen Infektion und Vergiftung von Bordetella |
GB8807860D0 (en) * | 1988-04-05 | 1988-05-05 | Connaught Lab | Pertussis vaccine |
US5101014A (en) * | 1989-02-10 | 1992-03-31 | United States Of America | Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis |
GB8910570D0 (en) * | 1989-05-08 | 1989-06-21 | Wellcome Found | Acellular vaccine |
US5276142A (en) * | 1989-12-11 | 1994-01-04 | American Cyanamid Company | Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis |
GB9007416D0 (en) * | 1990-04-02 | 1990-05-30 | Wellcome Found | Expression of heterologous protein in yeast |
GB9007657D0 (en) | 1990-04-04 | 1990-05-30 | Connaught Lab | Purification of a pertussis outer membrane protein(omp69) |
IT1248735B (it) * | 1990-06-21 | 1995-01-26 | Sclavo Spa | Vaccini acellulari contro la pertosse |
EP0484621A3 (en) | 1990-07-11 | 1992-08-26 | American Cyanamid Company | Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens |
-
1984
- 1984-05-12 GB GB848412207A patent/GB8412207D0/en active Pending
-
1985
- 1985-05-10 EP EP85303302A patent/EP0162639B1/de not_active Expired - Lifetime
- 1985-05-10 NO NO851878A patent/NO165478C/no not_active IP Right Cessation
- 1985-05-10 DK DK198502089A patent/DK165358C/da not_active IP Right Cessation
- 1985-05-10 DE DE8585303302T patent/DE3582272D1/de not_active Revoked
- 1985-05-10 AT AT85303302T patent/ATE61937T1/de active
- 1985-05-10 JP JP60099413A patent/JPH07116053B2/ja not_active Expired - Lifetime
- 1985-05-10 CA CA000481336A patent/CA1253073A/en not_active Expired
- 1985-05-10 FI FI851859A patent/FI81262C/fi not_active IP Right Cessation
- 1985-05-10 ES ES543026A patent/ES8802275A1/es not_active Expired
-
1994
- 1994-03-21 US US08/210,458 patent/US5648080A/en not_active Expired - Lifetime
- 1994-05-11 US US08/240,814 patent/US5438120A/en not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/470,590 patent/US6127151A/en not_active Expired - Lifetime
- 1995-06-07 US US08/478,046 patent/US6048700A/en not_active Expired - Lifetime
-
1997
- 1997-08-01 NO NO1997010C patent/NO1997010I1/no unknown
-
1998
- 1998-01-27 NL NL980006C patent/NL980006I1/nl unknown
- 1998-01-28 LU LU90203C patent/LU90203I2/fr unknown
-
1999
- 1999-06-17 US US09/334,690 patent/US6210685B1/en not_active Expired - Fee Related
- 1999-06-30 US US09/343,399 patent/US20020150595A1/en not_active Abandoned
- 1999-07-07 JP JP11193416A patent/JP2000072690A/ja active Pending
- 1999-07-07 JP JP11193312A patent/JP2000053585A/ja active Pending
-
2002
- 2002-09-16 US US10/243,930 patent/US20030077294A1/en not_active Abandoned
- 2002-12-27 US US10/329,946 patent/US20030108572A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA1253073A (en) | 1989-04-25 |
FI81262C (fi) | 1990-10-10 |
JPS60246321A (ja) | 1985-12-06 |
EP0162639A2 (de) | 1985-11-27 |
LU90203I2 (fr) | 1998-04-06 |
DK208985D0 (da) | 1985-05-10 |
US5648080A (en) | 1997-07-15 |
DK165358B (da) | 1992-11-16 |
ES8802275A1 (es) | 1988-05-01 |
US6048700A (en) | 2000-04-11 |
JP2000053585A (ja) | 2000-02-22 |
DK165358C (da) | 2000-11-06 |
ES543026A0 (es) | 1988-05-01 |
FI851859A0 (fi) | 1985-05-10 |
EP0162639B1 (de) | 1991-03-27 |
NO165478B (no) | 1990-11-12 |
US6210685B1 (en) | 2001-04-03 |
NL980006I1 (nl) | 1998-04-01 |
JPH07116053B2 (ja) | 1995-12-13 |
NO851878L (no) | 1985-11-13 |
US20030077294A1 (en) | 2003-04-24 |
DK208985A (da) | 1985-11-13 |
US20030108572A1 (en) | 2003-06-12 |
US6127151A (en) | 2000-10-03 |
JP2000072690A (ja) | 2000-03-07 |
US20020150595A1 (en) | 2002-10-17 |
GB8412207D0 (en) | 1984-06-20 |
US5438120A (en) | 1995-08-01 |
NO1997010I1 (no) | 1997-08-25 |
FI851859L (fi) | 1985-11-13 |
EP0162639A3 (en) | 1988-02-03 |
DE3582272D1 (de) | 1991-05-02 |
FI81262B (fi) | 1990-06-29 |
NO165478C (no) | 1991-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE61937T1 (de) | Antigenische zubereitungen und isolierung von solchen zubereitungen. | |
NL300402I1 (en) | Method and manufacture of an acellular vaccine comprising Bordetella pertussis antigens | |
ATE125568T1 (de) | Analoge der untereinheit des von rekombinanter dns abgeleiteten bordetella-toxins. | |
DK0396964T3 (da) | Pertussistoxin-mutanter, Bordetella-stammer, der er i stand til at producere sådanne mutanter, samt deres anvendelse til udvikling af antipertussis-vacciner | |
JPS5533497A (en) | Silaasubstituted 1*44dihydropyridine derivative | |
GR3006840T3 (de) | ||
DK0427462T3 (da) | Fremgangsmåde | |
EP0563288A4 (en) | Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines |